Current Pharmaceutical Design
Title: Editorial [Hot Topic: Membrane Channels as Therapeutic Targets (Executive Editor: Jean-Claude Herve)]
Volume: 12 Issue: 4
Author(s): Jean-Claude Herve
Affiliation:
Export Options
About this article
Cite this article as:
Herve Jean-Claude, Editorial [Hot Topic: Membrane Channels as Therapeutic Targets (Executive Editor: Jean-Claude Herve)], Current Pharmaceutical Design 2006; 12 (4) . https://dx.doi.org/10.2174/138161206775474495
DOI https://dx.doi.org/10.2174/138161206775474495 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
5-HT7 Receptors
Current Drug Targets - CNS & Neurological Disorders Current and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets Melatonin in the Biliary Tract and Liver: Health Implications
Current Pharmaceutical Design Relevance of CYP2C9 Function in Valproate Therapy
Current Neuropharmacology Modeling Rett Syndrome Using Human Induced Pluripotent Stem Cells
CNS & Neurological Disorders - Drug Targets Chemical Biology of mGlu4 Receptor Activation: Dogmas, Challenges, Strategies and Opportunities
Current Topics in Medicinal Chemistry Relevance of Breast Cancer Resistance Protein to Brain Distribution and Central Acting Drugs: A Pharmacokinetic Perspective
Current Drug Metabolism Cortical Auditory Dysfunction in Childhood Epilepsy: Electrophysiologic Evidence
Current Pediatric Reviews Inflammatory Process in Parkinsons Disease: Role for Cytokines
Current Pharmaceutical Design Could Event Related Potentials be a Key Prognostic Biomarker of Alzheimer’s Disease?
Current Alzheimer Research Blood-Brain Barrier P450 Enzymes and Multidrug Transporters in Drug Resistance: A Synergistic Role in Neurological Diseases
Current Drug Metabolism Treating Asthma as a Neuroelectrical Disorder
Inflammation & Allergy - Drug Targets (Discontinued) Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
Current Gene Therapy Delirium Secondary to Lamotrigine Toxicity
Current Drug Safety Cardio-Hepatic Metabolic Derangements and Valproic Acid
Current Clinical Pharmacology Diabetes, Cognitive Function, and the Blood-Brain Barrier
Current Pharmaceutical Design Recent Advances on the Possible Neuroprotective Activities of Epstein- Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System
Current Neuropharmacology CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets GPCR Allosteric Modulators: Mechanistic Advantages and Therapeutic Applications
Current Topics in Medicinal Chemistry SPECT Radiopharmaceuticals for Dementia
Current Radiopharmaceuticals